Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 15, 2005 (Vol. 25, No. 10)

Proteomics at the NCI

  • Good organization
  • Not deep enough
When I see a URL with a FLASH-based graphic on the opening page, I almost always wince, expecting a cheesy and annoying opening cartoon that doesn't do much more than waste my time. I'm happy to say the NCI Proteomics site actually put FLASH to good use, providing an attractive navigation scheme for visitors to use. Links to the major sections of the site are ready at the click of a button. They include Mass Spectrometry, Protein Chemistry, Protein Expression, Molecular Technology, Image analysis, and Bioinformatics. Most of the material under these links is related to services provided by the laboratory. This is a dandy way to organize information, but I must complain about being a bit dissapointed at the relatively low amount of information/analysis available for scientists. Still, there are a few gems worth at least a quick trip to the site.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »